Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022

Author's Avatar
Dec 05, 2022

Event will focus on CPI-818 (ITK inhibitor) clinical development and will take place at 4:30 pm ET / 1:30 pm PT